As of Apr 21
| -0.81 / -1.82%|
The 3 analysts offering 12-month price forecasts for Anika Therapeutics Inc have a median target of 54.00, with a high estimate of 60.00 and a low estimate of 51.00. The median estimate represents a +23.34% increase from the last price of 43.78.
The current consensus among 3 polled investment analysts is to Buy stock in Anika Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.